<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39318389</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>26</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2666-3643</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>JTO clinical and research reports</Title><ISOAbbreviation>JTO Clin Res Rep</ISOAbbreviation></Journal><ArticleTitle>Brief Report: Understanding Program-Level Impact of COVID-19 in Lung Cancer Screening Programs in the United States.</ArticleTitle><Pagination><StartPage>100709</StartPage><MedlinePgn>100709</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100709</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jtocrr.2024.100709</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">Lung cancer screening (LCS) reduces lung cancer mortality, yet uptake pre- and post-coronavirus disease 2019 (COVID-19) remains low. The impact of COVID-19 on LCS programs across the United States is unknown. Ours is the first multi-institutional study to identify barriers to LCS experienced during the pandemic. Our work will hopefully inform the development of targeted resources to facilitate increased uptake of LCS.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A nationwide survey of Centers of Excellence (SCOE) in LCS was conducted by GO2 for Lung Cancer Foundation. In 2021, survey items included questions regarding program structure, screening rates, and systemic barriers to LCS delivery experienced amid COVID-19.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 99 programs representing 1112 screening sites responded. A median of 868 patients were screened during the year of 2020. Patient recruitment, patient education, and in-person service access were negatively affected by COVID-19, whereas the use of telemedicine was positively affected. Coordination of care and timely reporting of results were largely unaffected by the pandemic.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Our findings provide a real-world snapshot of how COVID-19 affected LCS from a program perspective. These findings highlight ongoing challenges with educating and engaging those at high risk for lung cancer in LCS. Program resources should be directed toward increasing adherence to LCS among eligible patients.</AbstractText><CopyrightInformation>© 2024 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yong</LastName><ForeName>Valeda</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Surgery, Temple University Hospital, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lutzow</LastName><ForeName>Lynde</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Surgery, Temple University Hospital, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ciupek</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>GO2 for Lung Cancer, Washington, District of Columbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Criswell</LastName><ForeName>Angela</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>GO2 for Lung Cancer, Washington, District of Columbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>King</LastName><ForeName>Jennifer C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>GO2 for Lung Cancer, Washington, District of Columbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Grace X</ForeName><Initials>GX</Initials><AffiliationInfo><Affiliation>Center for Asian Health, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Erkmen</LastName><ForeName>Cherie P</ForeName><Initials>CP</Initials><AffiliationInfo><Affiliation>Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JTO Clin Res Rep</MedlineTA><NlmUniqueID>101769967</NlmUniqueID><ISSNLinking>2666-3643</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 pandemic</Keyword><Keyword MajorTopicYN="N">Early detection</Keyword><Keyword MajorTopicYN="N">Health care delivery</Keyword><Keyword MajorTopicYN="N">Lung cancer</Keyword><Keyword MajorTopicYN="N">Lung cancer screening</Keyword></KeywordList><CoiStatement>This work was (partially) supported by the National Cancer Institute of 10.13039/100000002National Institutes of Health (NCI/NIH) (TUFCCC/HC Regional Comprehensive Cancer Health Disparity Partnership, Award Number U54 CA221704[5]).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>6</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>25</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>25</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>25</Day><Hour>4</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39318389</ArticleId><ArticleId IdType="pmc">PMC11421313</ArticleId><ArticleId IdType="doi">10.1016/j.jtocrr.2024.100709</ArticleId><ArticleId IdType="pii">S2666-3643(24)00079-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Siegel R.L., Miller K.D., Wagle N.S., Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17–48.</Citation><ArticleIdList><ArticleId IdType="pubmed">36633525</ArticleId></ArticleIdList></Reference><Reference><Citation>National Lung Screening Trial Research Team. Aberle D.R., Adams A.M., et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365:395–409.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4356534</ArticleId><ArticleId IdType="pubmed">21714641</ArticleId></ArticleIdList></Reference><Reference><Citation>de Koning H.J., van der Aalst C.M., de Jong P.A., et al. Reduced lung-cancer mortality with volume CT screening in a randomized trial. N Engl J Med. 2020;382:503–513.</Citation><ArticleIdList><ArticleId IdType="pubmed">31995683</ArticleId></ArticleIdList></Reference><Reference><Citation>Haddad D.N., Sandler K.L., Henderson L.M., Rivera M.P., Aldrich M.C. Disparities in lung cancer screening: a review. Ann Am Thorac Soc. 2020;17:399–405.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7175982</ArticleId><ArticleId IdType="pubmed">32017612</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers of Medicare and Medicaid Services  CMS releases recommendations on adult elective surgeries, non-essential medical, surgical, and dental procedures during COVID-19 response. https://www.cms.gov/newsroom/press-releases/cms-releases-recommendations-adult-elective-surgeries-non-essential-medical-surgical-and-dental</Citation></Reference><Reference><Citation>Mazzone P.J., Gould M.K., Arenberg D.A., et al. Management of lung nodules and lung cancer screening during the COVID-19 pandemic: CHEST Expert Panel Report. Chest. 2020;158:406–415.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7177089</ArticleId><ArticleId IdType="pubmed">32335067</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Haren R.M., Delman A.M., Turner K.M., et al. Impact of the COVID-19 pandemic on lung cancer screening program and subsequent lung cancer. J Am Coll Surg. 2021;232:600–605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7947221</ArticleId><ArticleId IdType="pubmed">33346080</ArticleId></ArticleIdList></Reference><Reference><Citation>Henderson L.M., Benefield T., Bosemani T., Long J.M., Rivera M.P. Impact of the COVID-19 pandemic on volumes and disparities in lung cancer screening. Chest. 2021;160:379–382.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7784535</ArticleId><ArticleId IdType="pubmed">33417898</ArticleId></ArticleIdList></Reference><Reference><Citation>Copeland A., Criswell A., Ciupek A., King J.C. Effectiveness of lung cancer screening implementation in the community setting in the United States. J Oncol Pract. 2019;15:e607–e615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6625530</ArticleId><ArticleId IdType="pubmed">31150312</ArticleId></ArticleIdList></Reference><Reference><Citation>Henderson L.M., Marsh M.W., Benefield T.S., et al. Opinions and practices of lung cancer screening by physician specialty. N C Med J. 2019;80:19–26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6495571</ArticleId><ArticleId IdType="pubmed">30622199</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro S., Sosa E., Lozano V., et al. The impact of income and education on lung cancer screening utilization, eligibility, and outcomes: a narrative review of socioeconomic disparities in lung cancer screening. J Thorac Dis. 2021;13:3745–3757.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8264678</ArticleId><ArticleId IdType="pubmed">34277066</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufman H.W., Chen Z., Niles J., Fesko Y. Changes in the number of US patients with newly identified cancer before and during the coronavirus disease 2019 (COVID-19) pandemic. JAMA Netw Open. 2020;3</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7403918</ArticleId><ArticleId IdType="pubmed">32749465</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamadi H.Y., Zhao M., Haley D.R., Dunn A., Paryani S., Spaulding A. Medicare and telehealth: the impact of COVID-19 pandemic. J Eval Clin Pract. 2022;28:43–48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8657362</ArticleId><ArticleId IdType="pubmed">34786796</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozanne E.M., Noseworthy P.A., Cameron K.A., et al. Shared decision making in the era of telehealth: implications for practice and research. MDM Policy Pract. 2020;5</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7727056</ArticleId><ArticleId IdType="pubmed">33344769</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>